Observational studyJournal of clinical pharmacy and therapeutics2022

Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.

Erin Milner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.